Home 1.2

Your “External In-House Counsel”

Nearly 20 years of life-sciences legal & compliance experience

I provide hands-on interim support fully integrated into your organisation — aligned with internal processes, priorities, and business realities.

My role mirrors that of a senior in-house lawyer:

Close collaboration with legal, compliance, quality, and business teams
Practical, business-oriented advice — not abstract legal theory
Immediate availability for ongoing or urgent matters
Clear ownership of issues from assessment to resolution

The result is continuity, speed, and sound judgment — without lengthy onboarding or management overhead.

Extensive in-house experience supporting pharmaceutical, biotech, and medical device organisations across Switzerland and the EU.

I do not operate like a traditional external law firm.

Close collaboration with legal, compliance, quality, and business teams

Integrated interim support that works like part of your team

Immediate availability for ongoing or urgent matters and clear guidance in complex regulatory and organizational situations.

Practical, business-oriented advice — not abstract legal theory

Biography

Samantha Regenthal is a specialist in life sciences laws and regulations, based in Switzerland. Before founding her own company in 2014, Samantha worked as an inhouse counsel at F.Hoffmann-La Roche headquarters in Basel, Switzerland and as Head Legal Services at the life sciences boutique consultancy SFL in Basel, Switzerland.

She is counselling clients on legal, regulatory and compliance matters associated with pharmaceutical and medtech product development and marketing and is frequently involved in governance and policymaking activities. In addition, she possesses recognised expertise in EU competition
law.

As of 2025, Samantha is also active in the field of international arbitration and mediation,with a focus on life sciences disputes.

Samantha is a Swedish national. Her working languages are English, German and Swedish.

academic qualifications

CAS in Arbitration, Universities of Neuchâtel and Lucerne, Swiss Arbitration Academy, Switzerland, 2025
LL.M., University of Constance, Germany, 2007
CAS in Competition Law / Antitrust, University of Constance, Germany, 2006
Master of Laws, Lund University, Sweden, 2006

Publications

New Publication 2025

Investment Treaty Arbitration and Access to Medicines

In: ASA Bulletin Volume 43, Issue 1 (2025) pp. 7-33

Read It Here

Potential Impact on life-sciences. Proposed EU data protection regulation: Potential Impact on life-sciences

In: European Pharmaceutical Contractor, Fall 2014

Company Compliance

In: European Pharmaceutical Contractor, Winter 2013

Anmerkung zu EuGH, Urteil vom 26.4.2007, C-348/04Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.
("Remark to the Judgement in Case C-348/04 Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.")

In: GPR Zeitschrift für Gemeinschaftsprivatrecht, Feb. 2008

Die Beurteilung einer marktbeherrschenden Stellung unter besonderer Berücksichtigung des "more economic approach
The assessment of a dominant position in the light of „the more economic approach"")

In: Wirtschaft und Wettbewerb; vol. 56, afl. 12, pag. 1230-1237 / 2006, with Prof. Franz Böni , 2006

The law of abuse - a more economic approach to article 82

Master thesis, Lund University, Sweden 2006

INTERIM LIFE-SCIENCES LEGAL SUPPORT